Remove Disease Remove Doctors Remove Hospitals Remove Trials
article thumbnail

Zebrafish for Disease Modeling and Drug Screening in Pediatric Cancers

biobide

Pediatric cancers exhibit differences at the genetic level compared to the same form of adult disease, which may influence the selected treatment. This New Alternative Model (NAM) provides a platform for High-Content Screening through disease modeling through the transplantation of primary patient tumors into immunocompromised lines.

Disease 59
article thumbnail

Relieve Caregiver Burden, Improve Neurodegenerative Clinical Trials

PPD

For neurodegenerative disease research, the care partner, or caregiver, is equally important as the person with dementia. The care partners are the decision-makers for their loved ones with neurodegenerative disorders, handling everything from daily routines and medication management to doctor visits. There’s little time to lose.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How AI is accelerating the future of precision medicine

Drug Target Review

How does the integration of Real-World Data (RWD) with genomic biomarker data contribute to a more comprehensive understanding of disease progression and treatment response? Biomarker information is also useful for tracking progression of the disease and treatment response. Most drugs do not work in all people.

Doctors 109
article thumbnail

Australian discovery boosts hopes of preventing Type 1 diabetes

Drug Discovery World

Australian researchers based may be a step closer to preventing Type 1 diabetes after identifying a crucial protein that could prevent the autoimmune disease from taking hold. She has been fitted with an insulin pump, but her insulin resistance has meant she has spent a lot of time in doctors’ appointments and in hospital.

Doctors 130
article thumbnail

Sloane’s 1st ASO treatment

KIF1A

Fortunately, Sloane does not currently have epilepsy, and Megan hopes this treatment will prevent it’s onset as her disease progresses. On the day of the treatment, they checked into the hospital where Sloane was administered sedation medication. During sedation, Sloane also had an MRI to assess for cerebral atrophy.

article thumbnail

New Hope Against Diseases Marked by Progressive Scarring of Lung Tissue

The Pharma Data

15, 2021 — An inhaled medication might make every day physical activity a bit easier for patients with serious scarring of the lungs, a new clinical trial finds. 13 in the New England Journal of Medicine , involved patients with high blood pressure in the lungs caused by interstitial lung disease (ILD). FRIDAY, Jan.

Disease 52
article thumbnail

Trials Find Full-Dose Blood Thinners May Harm, Not Help, COVID Patients in ICU

The Pharma Data

23, 2020 — Because COVID-19 is known to raise the odds for dangerous blood clots, blood thinners have quickly become part of routine care for many hospitalized patients. One doctor on the frontlines of the pandemic agreed that full-dose anticoagulants come with hazards. The three trials are being conducted on four continents.

Trials 52